The ANSM decides, as a precautionary measure, to withdraw from the market macrotextured breast implants and breast implants with polyurethane-coated surfaces
Published in ANSM - Agence Nationale de Sécurité du Médicament, Breast Implant-Associated Anaplastic Large Cell Lymphoma BIA-ALCL and Breast Implants
More from ANSM - Agence Nationale de Sécurité du MédicamentMore posts in ANSM - Agence Nationale de Sécurité du Médicament »
More from Breast Implant-Associated Anaplastic Large Cell Lymphoma BIA-ALCLMore posts in Breast Implant-Associated Anaplastic Large Cell Lymphoma BIA-ALCL »
- EU – SCHEER – Minutes of the Working Group meeting on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) of 15 January 2020
- SCHEER Safety of breast implants WG – minutes of 4 November 2019 meeting
- EU – Minutes of the 24 July 2019 SCHEER Working Group on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) meeting
- TGA – Australian regulatory action on breast implants and breast tissue expanders
- The FDA Takes Action to Protect Patients from Risk of Certain Textured Breast Implants; Requests Allergan Voluntarily Recall Certain Breast Implants and Tissue Expanders from the Market: FDA Safety Communication
More from Breast ImplantsMore posts in Breast Implants »
- EU – SCHEER – Minutes of the Working Group meeting on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) of 15 January 2020
- SCHEER Safety of breast implants WG – minutes of 4 November 2019 meeting
- US FDA Draft Guidance – Breast Implants – Certain Labeling Recommendations to Improve Patient Communication
- EU – Minutes of the 24 July 2019 SCHEER Working Group on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) meeting
- TGA – Current status of breast implant products in Australia
Be First to Comment